Neurol. praxi. 2023;24(4):274-280 | DOI: 10.36290/neu.2023.010

Diagnosis of multiple sclerosis: can errors and mistakes occur?

doc. MUDr. Zbyšek Pavelek, Ph.D., prof. MUDr. Martin Vališ, Ph.D.
Neurologická klinika LF a FN Hradec Králové

Multiple sclerosis is a chronic inflammatory demyelinating disease which affect central nervous system. Early diagnosis is the goal due to high activity of imunopathological processes during the begining of this disease Misdiagnosis of multiple sclerosis remains a topical problem in current clinical practice. Studies indicate that misdiagnosed patients are often exposed to prolonged unnecessary health care risks. The clinician needs to be aware of alternative diagnoses, such as functional neurologic disorders, migraine, and vascular disease, along with uncommon inflammatory, infectious, and metabolic disorders that may mimic MS.

Keywords: multiple sclerosis, diagnosis, misdiagnosis.

Received: February 13, 2023; Revised: February 15, 2023; Accepted: February 17, 2023; Prepublished online: February 17, 2023; Published: September 8, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavelek Z, Vališ M. Diagnosis of multiple sclerosis: can errors and mistakes occur? Neurol. praxi. 2023;24(4):274-280. doi: 10.36290/neu.2023.010.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arrambide G, Tintore M, Espejo C, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain. 2018;141(4):1075-1084. Go to original source... Go to PubMed...
    2. Brownlee WJ. Use (and misuse) of the McDonald criteria to diagnose multiple sclerosis. Eur J Neurol. 2018;25:209-210. Go to original source... Go to PubMed...
    3. Carmosino MJ, Brousseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol. 2005;62:585-590. Go to original source... Go to PubMed...
    4. Efendi H. Clinically Isolated Syndromes: Clinical Characteristics, Differential Diagnosis, and Management. Noro Psikiyatr Ars. 2015;52(Suppl. 1):S1-S11 Go to original source... Go to PubMed...
    5. Feitová V. Současné možnosti a význam vyšetření magnetickou rezonancí v diagnostice roztroušené sklerózy mozkomíšní. Neurol. praxi. 2002;5:252-255.
    6. Garcea O, Villa A, Cáceres F, et al. Early treatment of multiple sclerosis: a Latin American experts meeting. Mult Scler. 2009;15(Suppl. 3):S1-S12. Go to original source... Go to PubMed...
    7. Kadaňka Z. Spondylogenní cervikální myelopatie. Cesk Slov Neurol N. 2010;73/106(3):209-226.
    8. Kaisey MGB. Misdiagnosis of multiple sclerosis and common alternate diagnoses. Mult Scler J. 2017;23:680-975. Go to original source... Go to PubMed...
    9. Kelly SB, Chaila E, Kinsella K, et al. Using atypical symptoms and red flags to identify non­‑demyelinating disease. J Neurol Neurosurg Psychiatry. 2012;83(1):44-8. Go to original source... Go to PubMed...
    10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-7. Go to original source... Go to PubMed...
    11. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14(9):1157-74. Go to original source... Go to PubMed...
    12. Neema M, Guss ZD, Stankiewicz JM, et al. Normal findings on brain FLAIR MRI scans at 3 T. AJNR Am J Neuroradiol. 2009;30:911-916. Go to original source... Go to PubMed...
    13. Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800-5. Go to original source... Go to PubMed...
    14. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. Go to original source... Go to PubMed...
    15. Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist. 2007;13(2):57-72 Go to original source... Go to PubMed...
    16. Sadaka Y, Verhey LH, Shroff MM, et al.; Canadian Pediatric Demyelinating Disease Network. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol. 2012;72(2):211-23. Go to original source... Go to PubMed...
    17. Scalfari A, Neuhaus A, Daumer M, et al. Onset of secondary progressive phase and long­‑term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2014;85(1):67-75. Go to original source... Go to PubMed...
    18. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci. 1965;122:552-68. Go to original source... Go to PubMed...
    19. Solomon AJ, Bourdette DN, Cross AH, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology. 2016;87(13):1393-9. Go to original source... Go to PubMed...
    20. Solomon AJ, Corboy JR. The tension between early diagnosis and misdiagnosis of multiple sclerosis. Nat Rev Neurol. 2017;13:567-572. Go to original source... Go to PubMed...
    21. Solomon AJ, Naismith RT, Cross AH. Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice. Neurology. 2019;92(1):26-33. Go to original source... Go to PubMed...
    22. Tintoré M. Rationale for early intervention with immunomodulatory treatments. J Neurol. 2008;255(Suppl. 1):37-43. Go to original source... Go to PubMed...
    23. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. Go to original source... Go to PubMed...
    24. Toledano M, Weinshenker BG, Solomon AJ. A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis. Curr Neurol Neurosci Rep. 2015;15(8):57. Go to original source... Go to PubMed...
    25. Vališ M, Pavelek Z. Roztroušená skleróza pro praxi. Praha: Maxdorf, 2020. Jessenius. ISBN 978-80-7345-573-6.
    26. Weber MS, Derfuss T, Metz I, Brück W. Defining distinct features of anti­‑MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord. 2018;11:1756286418762083. Go to original source... Go to PubMed...
    27. Wen W, Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year­‑old individuals. Neuroimage. 2004;22:144-154. Go to original source... Go to PubMed...
    28. Wingerchuk DM, Banwell B, Bennett JL, et al.; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-89. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.